TH138528A - - Google Patents

Info

Publication number
TH138528A
TH138528A TH701005025A TH0701005025A TH138528A TH 138528 A TH138528 A TH 138528A TH 701005025 A TH701005025 A TH 701005025A TH 0701005025 A TH0701005025 A TH 0701005025A TH 138528 A TH138528 A TH 138528A
Authority
TH
Thailand
Prior art keywords
nucleic acid
peptide
peptides
provides
treatment
Prior art date
Application number
TH701005025A
Other languages
English (en)
Thai (th)
Original Assignee
นางดารานีย์ วัจนะวุฒิวงศ์ นางสาวสนธยา สังขพงศ์ นายณัฐพล อร่ามเมือง
Filing date
Publication date
Application filed by นางดารานีย์ วัจนะวุฒิวงศ์ นางสาวสนธยา สังขพงศ์ นายณัฐพล อร่ามเมือง filed Critical นางดารานีย์ วัจนะวุฒิวงศ์ นางสาวสนธยา สังขพงศ์ นายณัฐพล อร่ามเมือง
Publication of TH138528A publication Critical patent/TH138528A/th

Links

TH701005025A 2007-10-04 TH138528A (de)

Publications (1)

Publication Number Publication Date
TH138528A true TH138528A (de) 2014-12-30

Family

ID=

Similar Documents

Publication Publication Date Title
ATE531383T1 (de) Therapeutische verwendung eines wachstumsfaktors, metrnl
DE60327786D1 (de) Kdr-peptide und diese enthaltende impfstoffe
BRPI0507026A (pt) proteìnas de fusão de albumina
EA200800368A1 (ru) Гликозилированный il-7, получение и применение
WO2010135491A3 (en) Fibroblast growth factor mutants having improved functional half-life and methods of their use
ATE481978T1 (de) Zusammensetzungen und verfahren zur behandlung von herzkrankheiten
Dietz et al. Peptide-enhanced cellular internalization of proteins in neuroscience
EA202092176A1 (ru) 177Lu-DOTA-HYNIC-iPSMA В КАЧЕСТВЕ ТЕРАПЕВТИЧЕСКОГО РАДИОФАРМАЦЕВТИЧЕСКОГО СРЕДСТВА, НАЦЕЛЕННОГО НА ПРОСТАТИЧЕСКИЙ СПЕЦИФИЧЕСКИЙ МЕМБРАННЫЙ АНТИГЕН
IN2012DN02981A (de)
NZ592911A (en) Leukolectins and uses thereof
ATE509096T1 (de) Von sparc abgeleitetes krebsabstossungsantigenpeptid und pharmazeutikum, das dieses enthält
DK1745069T3 (da) Terapeutisk anvendelse af vækstfaktoren NSG33
CY1118840T1 (el) Πρωτοτυπα πεπτιδια για θεραπευτικη και προληπτικη αγωγη ανοσοσχετιζομενων διαταραχων, που περιλαμβανει θεραπευτικη και προληπτικη αγωγη λοιμωξης διαμορφωνοντας εγγενη ανοσια
WO2006119767A3 (en) Neuritogenic peptides
BRPI0416434A (pt) métodos para aumentar a atividade de uma proteìna de ácido esfingomielinase (asm), para estender a meia-vida e prolongar a atividade de uma proteìna asm purificada, para aumentar a produção de uma proteìna asm recombinante através de uma célula hospedeira, e usos de uma composição de asm tipo alelo-selvagem, purificada e um composto análogo de ceramida ou esfingomielina, e de um composto análogo de ceramida ou de esfingomielina
TH138528A (de)
ATE399803T1 (de) Gleichmässig hinhaltend ein aminosäurederivat freisetzendes polymer, kosmetikum und faserkonstrukt mit dem polymer, herstellungsverfahren dafür und regenerationsverfahren dafür
PL1636261T3 (pl) Białka trombopoetynowe o ulepszonych właściwościach
WO2005123760A3 (en) Treating cancer
TW200724679A (en) Treatment of disease using an improved regulated expression system
WO2004078918A3 (en) Materials and methods relating to therapy and diagnosis using targeting of cells that express dcal-hy polypeptides
CN117396218A (zh) 疼痛和炎性疾病的治疗
DE602005021159D1 (de) Bakteriophagen- und prophagen-proteine in der krebsgentherapie
ATE556135T1 (de) Neues protein
GB0426960D0 (en) TGR-3 like protein receptor